Abstract
According to the fact sheet released by World Health Organization (WHO), an estimated 240 million people worldwide are chronically infected with the hepatitis B virus (HBV). HBV-related diseases, such as liver failure, liver cirrhosis, and hepatic cell carcinoma (HCC), result in approximately 600 thousand deaths per year [1]. An estimated 150 million people are infected with the hepatitis C virus (HCV), and 350 thousand mortalities per year are HCV related [2]. As one of the most widespread epidemic diseases in China, the positivity rate for the HBV surface antigen is 7.18 % [3]. In addition, epidemiological surveys revealed that in 2006, there were more than 93 million people infected with chronic HBV, of whom approximately 20 million are chronic HBV patients. Common diseases associated with HBV infection include acute and chronic HBV hepatitis, HBV-related liver cirrhosis, and HBV-related HCC. The incidence of HCC in China is approximately 350 thousand per year, accounting for 55 % of global incidences. HCC also ranks the second in cancer-related mortality, compromising the well-being of individuals and causing an enormous financial burden on the family, society, and the country. In China, 95 % of HCC originates from a background of HBV infection, and liver fibrosis plays a major role in the progression from HBV infection to liver cirrhosis and ultimately possible to HCC. Liver fibrosis is not a single disease entity but a common pathological process in almost every type of chronic liver disease. It is characterized by increased synthesis of extracellular matrix proteins, primarily via interstitial cells especially activated hepatic stellate cells, with subsequent excess deposition of fibrous connective tissue in the liver [4]. This increased synthesis and excess deposition result in structural disturbances of the hepatic lobules and the formation of pseudolobules, an effect that gradually advances to cirrhosis and liver dysfunction. The main causes of liver fibrosis are infection with hepatotropic viruses (HBV and HCV), alcohol abuse, and nonalcoholic fatty liver disease. The progression of liver fibrosis is relatively slow, usually taking a decade or even several decades for the initial fibrosis in the portal triads to form fibrous septa, which damage the hepatic lobules and to ultimately progress to cirrhosis. Excluding cirrhosis, liver fibrosis is considered to be reversible under certain circumstances; therefore, early diagnosis and dynamic surveillance of liver fibrosis is crucial. With observation, it is possible to determine the proper starting time for treatment, to evaluate drug efficacy, to stage the disease, and to evaluate its prognosis. Thereby, the accurate staging of liver fibrosis is of great importance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 dex. WHO Web site. http://www.who.int/mediacentre/factsheets/fs204/en/.
World Health Organization. Hepatitis C. World Health Organization Fact Sheet 164 dex. WHO Web site. http://www.who.int/mediacentre/factsheets/fs164/zh/.
Feng Y-H, Qian L-X, Hu X-D. Advances in ultrasonic diagnosis of hepatic fibrosis and early cirrhosis. World Chin J Digestology. 2010;15(8):454–61.
Liang H, Wang D. Current advances in imaging evaluation of liver fibrosis. Int J Med Radiol. 2011;34(3):261–5.
Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372–4.
Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6):1449–57.
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32(3):477–81.
Cosgrove D, Piscaglia F, Bamber J, et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: clinical applications. Ultraschall Med. 2013;34(3):238–53.
EASL. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2014;60(2):392–420.
Ophir J, Cespedes I, Ponnekanti H, et al. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging. 1991;13(2):111–34.
Balleyguier C, Canale S, Ben HW, et al. Breast elasticity: principles, technique, results: an update and overview of commercially available software. Eur J Radiol. 2013;82(3):427–34.
Catheline S, Thomas JL, Wu F, et al. Diffraction field of a low frequency vibrator in soft tissues using transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control. 1999;46(4):1013–9.
Sandrin L, Tanter M, Catheline S, et al. Shear modulus imaging with 2-D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control. 2002;49(4):426–35.
Chon YE, Choi EH, Song KJ, et al. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One. 2012;7(9):e44930.
Myers RP, Elkashab M, Ma M, et al. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Can J Gastroenterol. 2010;24(11):661–70.
Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 2009;16(1):36–44.
Stebbing J, Farouk L, Panos G, et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol. 2010;44(3):214–9.
Sturm N, Marlu A, Arvers P, et al. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C. Liver Int. 2013;33(3):428–38.
Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54(1):64–71.
Wong VW, Chan HL. Transient elastography. J Gastroenterol Hepatol. 2010;25(11):1726–31.
Nightingale K, Soo MS, Nightingale R, et al. Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol. 2002;28(2):227–35.
Rifai K, Cornberg J, Mederacke I, et al. Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Dig Liver Dis. 2011;43(6):491–7.
Zhang D, Chen M, Wang R, et al. Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol. 2015;41(1):7–14.
Cassinotto C, Lapuyade B, Mouries A, et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®. J Hepatol. 2014;61(3):550–7.
Friedrich-Rust M, Nierhoff J, Lupsor M, et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012;19(2):e212–9.
Bota S, Sporea I, Peck-Radosavljevic M, et al. The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. Dig Liver Dis. 2013;45(9):762–8.
Bota S, Sporea I, Sirli R, et al. Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of Acoustic Radiation Force Impulse (ARFI) elastography--analysis of a cohort of 1,031 subjects. Eur J Radiol. 2014;83(2):268–72.
Zheng Y, Chen S, Tan W, et al. Detection of tissue harmonic motion induced by ultrasonic radiation force using pulse-echo ultrasound and Kalman filter. IEEE Trans Ultrason Ferroelectr Freq Control. 2007;54(2):290–300.
Ma JJ, Ding H, Mao F, et al. Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: a comparison with liver pathological results. J Gastroenterol Hepatol. 2014;29(4):814–9.
Ling W, Lu Q, Quan J, et al. Assessment of impact factors on shear wave based liver stiffness measurement. Eur J Radiol. 2013;82(2):335–41.
Sarvazyan AP, Rudenko OV, Swanson SD, et al. Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics. Ultrasound Med Biol. 1998;24(9):1419–35.
Bercoff J, Tanter M, Fink M. Supersonic shear imaging: a new technique for soft tissue elasticity mapping. IEEE Trans Ultrason Ferroelectr Freq Control. 2004;51(4):396–409.
Jeong JY, Kim TY, Sohn JH, et al. Real time shear wave elastography in chronic liver diseases: accuracy for predicting liver fibrosis, in comparison with serum markers. World J Gastroenterol. 2014;20(38):13920–9.
Zeng J, Liu GJ, Huang ZP, et al. Diagnostic accuracy of two-dimensional shear wave elastography for the non-invasive staging of hepatic fibrosis in chronic hepatitis B: a cohort study with internal validation. Eur Radiol. 2014;24(10):2572–81.
Ferraioli G, Tinelli C, Dal Bello B, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012;56(6):2125–33.
Deffieux T, Gennisson JL, Bousquet L, et al. Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. J Hepatol. 2015;62(2):317–24.
Huang Z, Zheng J, Zeng J, et al. Normal liver stiffness in healthy adults assessed by real-time shear wave elastography and factors that influence this method. Ultrasound Med Biol. 2014;40(11):2549–55.
Wang CZ, Zheng J, Huang ZP, et al. Influence of measurement depth on the stiffness assessment of healthy liver with real-time shear wave elastography. Ultrasound Med Biol. 2014;40(3):461–9.
Tohno E, Ueno E. Current improvements in breast ultrasound, with a special focus on elastography. Breast Cancer. 2008;15(3):200–4.
Koizumi Y, Hirooka M, Kisaka Y, et al. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography establishment of the method for measurement. Radiology. 2011;258(2):610–7.
Gheorghe L, Iacob S, Gheorghe C. Real-time sonoelastography-a new application in the field of liver disease. J Gastrointestin Liver Dis. 2008;17(4):469–74.
Wu T, Ren J, Cong SZ, et al. Accuracy of real-time tissue elastography for the evaluation of hepatic fibrosis in patients with chronic hepatitis B: a prospective multicenter study. Dig Dis. 2014;32(6):791–9.
Morishita S, Hirooka Y, Sato K, et al. Real-time tissue elastography in chronic liver disease. Rinsho Byori. 2010;58(4):319–24.
Wang J, Guo L, Shi X, et al. Real-time elastography with a novel quantitative technology for assessment of liver fibrosis in chronic hepatitis B. Eur J Radiol. 2012;81(1):e31–6.
Jie Z, Rongqin Z, Zhongzhen SU, et al. Evaluation of hepatic stiffness by ultrasonic elastography quantitative analysis: preliminary experience. Chin J Med Ultrasound Electron Ed. 2011;8(9):1958–63.
Morikawa H, Fukuda K, Kobayashi S, et al. Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C. J Gastroenterol. 2011;46(3):350–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lu, Q., Ling, W. (2016). Ultrasound Elastography in the Assessment of Liver Fibrosis. In: Yan, L. (eds) Operative Techniques in Liver Resection. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7411-6_6
Download citation
DOI: https://doi.org/10.1007/978-94-017-7411-6_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7409-3
Online ISBN: 978-94-017-7411-6
eBook Packages: MedicineMedicine (R0)